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Abstract
Background: V a r i a t i o ni np r e - m R N As p l i c i n gi sc o m m o na n di ns o m ec a s e sc a u sed by genetic variants in intronic splicing motifs. Recent
studies into the insulin gene (INS) discovered a polymorphism in a 59non-coding intron that influences the likelihood of intron retention in
the final mRNA, extending the 59untranslated region and maintaining protein quality. Retention was also associated with increased insulin
levels, suggesting that such variants - splice translational efficiency polymorphisms (STEPs) - may relate to disease phenotypes through
differential protein expression. We set out to explore the prevalence of STEPs in the human genome and validate this new category of
protein quantitative trait loci (pQTL) using publicly available data.
Methodology/Principal Findings: Gene transcript and variant data were collected and mined for candidate STEPs in motif
regions. Sequences from transcripts containing potential STEPs were analysed for evidence of splice site recognition and an
effect in expressed sequence tags (ESTs). 16 publicly released genome-wide association data sets of common diseases were
searched for association to candidate polymorphisms with HapMap frequency data. Our study found 3324 candidate STEPs
lying in motif sequences of 59 non-coding introns and further mining revealed 170 with transcript evidence of intron
retention. 21 potential STEPs had EST evidence of intron retention or exon extension, as well as population frequency data
for comparison.
Conclusions/Significance: Results suggest that the insulin STEP was not a unique example and that many STEPs may occur
genome-wide with potentially causal effects in complex disease. An online database of STEPs is freely accessible at http://
dbstep.genes.org.uk/.
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Introduction
Alternative splicing of pre-mRNA is common in human and
other species [1]. Alternative splicing events have been recognised
for their effects on protein coding sequences, because most exons
contain protein coding sequence which may therefore be present
or absent in the translation product, hence altering the qualities of
the protein produced [2]. Alternative protein versions may
subserve different functions, a classic example being calcitonin
expressed from thyroid C cells versus CGRP as a neurotransmitter
produced by some nerve cells [3]. Such pre-mRNA splicing may
be tissue-specific and is equivalent between all individuals in a
population, but some is individual-specific because the alleles of a
polymorphism differentially affect splicing through their presence
in or effect on splicing sequence motifs. For example, a branch
point SNP, rs17266594 leads to the D2 isoform of BANK1 protein
which lacks a putative IP3R-binding domain, altering B cell
signalling and activity and SLE disease risk [4]. Similarly, SNP
rs6897932 in a putative exonic splice enhancer in IL7R seems to
affect exon 6 splicing, amounts of soluble versus membrane-bound
IL7R and risks of multiple sclerosis [5] and type 1 diabetes [6].
In a study of the human insulin gene (INS), we recognised in
silico, subsequently confirmed in vitro and in silico [7], and later in
vivo by others [8,9], that polymorphism in a 59 non-coding intron
(separating non-coding exon 1 from coding exon 2) could
influence intron retention in the final mRNA. In addition to
transcriptional effects, there were major proinsulin expression
effects, possibly due to the different 59 untranslated sequence in the
message [10]. Messenger RNA 59 untranslated sequence upstream
of the initiator methionine is well known to be able to influence
translational efficiency whether through ease of ribosomal roll
through from the 59 cap [11], through internal ribosomal entry
sites [12], or through specific regulatory elements [13]. Since
about 30% of (vertebrate) genes have at least one 59 non-coding
exon [14], polymorphisms like the INS ‘‘-23HphI’’ (IVS1-6A/T)
site affecting mRNA 59 untranslated sequence but not affecting the
protein sequence, represent a potentially substantial contribution
to protein quantitative trait loci (pQTLs), alongside promoter
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polymorphisms. This hitherto unrecognised class of potentially
functional variants we designated as ‘STEPs’ (Splice Translational
Efficiency Polymorphisms) [15], a class of polymorphisms in non-
coding RNA that may affect splicing such as to alter translational
efficiency.
We conducted a genome-wide sequence analysis of 59
untranslated region (UTR) intron and variant information
gathered from online databases to identify possible STEPs. Using
computational methods we collected data from publicly available
sources to find candidate STEPs in consensus regions of introns
and in transcripts displaying alternative splicing around the
candidate STEP. We further examined candidate STEPs in silico
for splice site recognition using sequences containing each SNP
allele and for expressed sequence tag (EST) evidence of intron
retention where possible. Presented here are results of this search,
along with 21 potential intron retaining or exon extending STEPs
where allele population frequency and EST data has shown a
disproportionate retention of one STEP allele, as well as a spliced
form. We also developed an online database, dbSTEP (http://
dbstep.genes.org.uk/), with current candidate STEPs annotated.
Results
Our genome-wide analysis and mining of transcript and variant
data found 9944 genes containing 59 UTR introns and resulted in
a database of 3324 candidate STEPs (see dbSTEP summary in
Table 1) covering 1820 Ensembl and 1117 Vega genes. SNPs
represented a 78% majority of these variants, but a large number
of variants were short insertions or deletions (INDELs) and do not
have HapMap frequency data available. The polypyrimidine tract
(PPT) was the most common intronic region for a candidate
STEP, with 1829 variants (1381 SNPs, 424 INDELs and 24 other
– e.g. Multi-Nucleotide Polymorphism or mixed). The fewest
number of variants appears in the shortest intronic motif, the 39
acceptor splice site (39ss), with 326 variants (248 SNPs, 78
INDELs). We found a disproportionate number of candidate
STEPs for the 12 nucleotide length of PPT searched using the
PWM of Zhang et al. [16] (where PPT is range 24t o215), with
3.03 and 5.61 times more candidates in the PPT than in the 59ss
(half the length of the PPT) and 39ss (quarter the length of the
PPT) regions. For each intron we found a mean allelic score
difference (non-consensus probability score difference between
each allele of a variant at a position in the intron) of 0.367, with a
standard deviation of 0.465 and a much higher maximum
difference for a 59ss candidate STEP. We also calculated a disease
impact score for each candidate STEP. The mean disease impact
score was 1.473 across all possible candidate STEP-motif pairings,
with a standard deviation of 1.171 and a much higher maximum
value for a SNP in the PPT.
Using the above content we scanned all 3324 candidate STEPs
for any transcript evidence of 3 different splicing patterns: intron
retention, alternative splice site (including extending, shortening or
skipping exons) and alternative upstream transcript start. The
Table 1. Summary of dbSTEP content.
59 splice site 39 splice site Branch point Polypyrimidine tract Total
Number of candidate STEPs 603 326 566 1,829 3,324
a
CEU
b 77 25 73 236 411
CHB
b 74 20 69 222 385
YRI
b 85 23 77 245 430
JPT
b 72 22 67 220 381
SNPs 511 248 458 1,381 2,598
Transitions 309 174 281 895 1,659
Transversions 199 73 177 483 932
Tri-allelic 31 0 3 7
IN-DELs 90 78 108 424 700
Other 20 0 2 4 2 6
Disease impact
c
Mean 1.638 1.250 1.322 1.490 1.473
Std. Dev. 1.752 1.404 0.676 1.009 1.171
Max 8.838 8.022 3.651 14.918 14.918
Min 0 0.123 0.071 0.036 0
Allelic Score Difference
c
Mean 0.633 0.848 0.384 0.194 0.367
Std. Dev. 0.678 0.510 0.508 0.167 0.465
Max 4.070 2.700 2.048 0.780 4.070
Min 00 0 0 0
a7 candidate STEPs appear in different motif regions depending on their location in different transcripts. 36 candidate STEPs appear in different chromosomes
depending on dbSNP mapping.
bHapMap data.
cParameters explained in text.
A summary of dbSTEP content constructed from mining of 59251 59 UTR intron sequences (22553 Ensembl; 36698 Vega) including that from 33372 transcripts (15056
Ensembl; 18316 Vega) from 9944 genes (9111 Ensembl; 5964 Vega).
doi:10.1371/journal.pone.0013340.t001
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with 2558 Ensembl and dbSNP polymorphisms, followed by the
alternative splice site group with 1806. The group with the fewest
candidates was the intron retention group, containing 170
variants. Of the 170 variants in retained introns, 24 had HapMap
minor allele frequencies (MAFs) available for comparison with
allele frequencies found in searches of EST data sets (Table 2).
EST analysis of potential intron retaining or exon
extending STEPs
Candidate STEPs relating to intron retaining transcripts were
mined using an online BLAST search of dbEST [17] for evidence
of intron retention in mRNA. Results from EST mining of 143
SNP-intron matches (a subset of the 170 variants that included
INDELs) yielded 92 possible STEPs with EST sequences spanning
the whole retained intron, as well as EST sequences matching a 40
base sequence spanning the spliced exon-exon junction (20 bases
either side). INDELs were excluded from this analysis due to a lack
of population frequency data. Of the 92 SNPs exhibiting spliced
and unspliced forms, 11 had HapMap-CEU MAFs (see Table 3).
Interestingly, all these 11 cases were polymorphic in either the 59ss
or at least 27 bases from the 39ss (in the PPT) and no likely
cases for intron retention were found in either the branch point or
the 39ss.
In addition to the intron retention search, this method was
repeated for partial intron retention where an exon was extended
to include the STEP. Of 508 candidate STEPs scanned (including
the 170 candidate intron retaining STEPs), where the STEP was
both intronic and exonic by transcript data, an additional 72 SNPs
were found to have evidence of alternative splicing by EST
evidence. Only 10 of these carried both HapMap allele frequency
data as well as EST evidence of spliced and unspliced forms (see
Table 3). This set included 1 39ss candidate, 2 59ss candidates, 4
polypyrimidine tract candidates and 3 branch point candidates.
Alternative splicing of shorter introns (under 700 bases) was related
to a candidate STEP in either the 3-base 39ss or the 6-base 59ss,
while all branch point candidates related to introns of lengths of
3759, 4774 and 35401.
Splice site prediction of candidate STEPs
All 2140 splice site and polypyrimidine tract candidate STEP
SNPs (4633 SNP-transcript cases) from within 59 and 39 end
PWMs, run through three splice site prediction tools [18–20]
resulted in 1980 candidate STEPs (4317 SNP-transcript cases)
where an allelic difference between predictions was greater than
zero for any prediction tool. A total of 1423 of these candidates
resulted in a difference greater than zero in 2 or more splice
prediction tools. The most predictions came from Human Splice
Finder (3788 SNP-transcripts, average difference 16.19%), fol-
lowed by a neural network splice site prediction tool, NNSplice
(3142 SNP-transcripts, average difference 31.03%) and the least
from NetUTR (1468 SNP-transcripts, average difference 37.26%),
based on the NetGene2 splice prediction tool and trained on a
data set of UTR splice patterns. The distribution of these results
for different attributes is shown in Figure S1. NNSplice results in a
wide range of difference scores between alleles, unlike HSF, where
differences were either quite low (,10%) or quite high (.65%).
The majority of cases resulting in a high difference were due to no
prediction of a splice site for the alternative allele. There was no
correlation between score difference and either GC-richness,
intron length or the number of known transcripts for a gene.
Final results set
Combining these results we found 15 SNPs where there existed
evidence of alternative splicing among gene transcripts and in EST
databases, as well as differential predictions of splice site quality
and HapMap minor allele frequencies. These results represent the
most likely candidates among our 3324 candidates in dbSTEP.
Discussion
The paradigm for this pQTL mechanism has been the human
insulin gene and we set out to find other polymorphisms genome-
wide that exhibit this effect. Our annotation of human 59 UTR
intron sequences has found many candidate polymorphisms which
may cause major effects on the expression level of specific proteins
through differential splicing of 59 non-coding regions in the final
mRNA.
Our results show STEPs to be potentially common throughout
the genome, with 1820 Ensembl genes occurring in our candidate
list and 1117 from the Vega database. It is unsurprising to find
more candidate STEPs per length of DNA in the PPT than in
other intron motifs as the PPT is both a much longer motif and
appears to have a lower specificity by the PWMs. Shorter and
higher specificity regions (59ss and 39ss) have less candidates per
base, with 59ss candidates (a 6 base consensus) double that of the
39ss (a 3 base consensus). The number of candidate STEPs near
exons causing an upstream transcript start (UTS) is an interesting
result, perhaps illustrating that the common scenario of alternative
splicing in 59 untranslated sequences results in an alternative first
exon and not so commonly the activation of a cryptic splice site
[21] or exon skipping. It may also be an artefact of the high
number of fragmented or non-coding Ensembl and Vega
transcripts currently available.
Table 2. Summary of candidate STEPs in alternatively spliced transcripts.
Intron retention Alternative splice site Upstream transcript start
Candidates 170 1806 2558
with frequencies 24 231 330
in 59 splice site 45 362 483
in 39 splice site 16 188 235
in branch point 12 306 454
in polypyrimidine tract 98 957 1391
A STEP causes intron retention if a transcript exists with an exon completely spanning the intron containing the STEP, activation of an alternative splice site if there
exists an intron that incompletely overlaps the intron containing the STEP or activation of an upstream transcript start site if there are no overlapping sequences and
other transcripts.
doi:10.1371/journal.pone.0013340.t002
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10 disease impact scores (see methods) ranging from 2.72 to 3.75
exclusive of genes in the HLA region of chromosome 6 [22]. This
score is used as a rough estimate to indicate possible disease
association through LD with reported SNPs in a collection of
genome-wide association studies (see Table S5) where possible.
Since the majority of candidate STEPs are not represented or
tagged in any of the 16 GWAS data sets in Table S5 and have no
background frequency data available, no further conclusions can
be made as to their disease impact or their abundance in vivo.
EST analysis
We used expressed sequence tag data analysis, as was done for
the INS gene [7], to provide an initial validation in silico of whether
alternative splicing around a candidate STEP is seen often in vivo.
One prediction was that polymorphisms at ‘‘obligate’’ splice site
consensus bases could have a stronger affect on intron retention by
causing splicing and non-splicing alleles and a more definitive
change in splicing efficiency. Of the final set of intron retaining or
exon extending gene transcript suggested by EST and prediction
evidence (Table 3), 3 of 21 STEPs are from obligate 59ss bases
(TTC12, GALNT11 and PPIG). In both TTC12 and GALNT11
cases there is evidence that the efficient splicing allele is retained,
suggesting other effects. In the case of PPIG we find only retention
of the minor allele, in this case the non-consensus A. Despite only
4 EST samples displaying exon extension, this candidate lies at an
obligatory splice site position (G allele necessary for splicing) with a
rare MAF and 50 EST samples showing the spliced form,
suggesting an effect on splicing.
Another prediction was that intron retention would have more
biological impact as retention is likely to involve many more
nucleotides than other alternative splicing patterns, extending the
59 UTR by a greater length and therefore exhibiting a more
substantial effect on translation. Table 3 shows a disease impact
score (see methods) as an estimate of disease association for a given
SNP. Many SNPs appear to show a modest effect where tagged
and many of these SNPs were not sufficiently tagged in all GWAS
datasets. Five candidate STEPs scored highly for disease impact:
Peptidyl-prolyl isomerise G (PPIG), DNA polymerase delta 2
(POLD2), bromodomain testis-specific (BRDT) and alpha-2-mac-
roglobulin (A2M).
Peptidyl-prolyl isomerise G (PPIG), also known as Cyclophilin
G, is one of 16 known human cyclophilins involved in protein
folding. The precise function of Cylcophilin G is unknown [23],
but has been experimentally shown to interact with CDC-Like
kinase (CLK) and Pinin (PNN), two serine/arginine-rich (SR)
proteins that are essential for pre-mRNA splicing [23]. Pinin
interacts with RNA-binding protein S1 (RNPS1), known to
regulate alternative splicing [24]. Previous research has suggested
that Cyclophilin G could bind to other SR proteins before being
transported into the nucleus, located to nuclear speckles and assist
in the folding of the spliceosome [25]. Previous research [10]
Table 3. List showing 21 candidate STEPs with evidence of alternative splicing in Ensembl/Vega transcripts, HapMap minor allele
frequencies greater than zero and BLAST EST evidence of intron retention (above dotted line) or exon extension (below dotted
line).
SNP Gene Disease Impact
a Region
b
HapMap MAF
(samples)
BLAST EST MAF
(samples)
BLAST EST
Un-spliced/
Spliced
rs4674259 CXCR2 1.02 ppt 0.483(120) 0.070(100) 100/4
rs11165878 BRDT 1.95 59ss 0.242(120) 0.800 (20) 20/19
rs2236709 TTC12 1.18 59ss 0.225(120) 1.000 (4) 4/6
rs3087370 POLD2 2.26 ppt 0.284(118) 0.125 (96) 96/2
rs2738364 PPP2R3B - ppt 0.267(120) 1.000 (2) 2/15
rs226380 A2M 1.94 ppt 0.450(120) 0.750 (16) 16/3
rs9508887 PSPC1 1.41 ppt 0.217(120) 0.333 (99) 99/10
rs915942 RPL10 0.76 59ss 0.057(88) 0.130(100) 100/50
rs4881111 PITRM1 1.61 ppt 0.442(120) 1.000 (2) 2/50
rs1859143 COL25A1 1.10 59ss 0.483(120) 0.400 (10) 10/1
rs17173334 GALNT11 1.21 59ss 0.025(120) 0.000 (5) 5/19
rs10912675 FMO1 1.09 ppt 0.325(120) 0.600 (20) 20/36
rs2276611 PPIG 2.49 59ss 0.093(118) 1.000 (4) 4/50
rs924900 ZNF713 0.68 ppt 0.033(120) 1.000 (3) 3/12
rs2076689 PLCB1 1.92 ppt 0.110(118) 0.000 (2) 2/32
rs1045761 TCEAL7 -3 9ss 0.467(90) 0.325 (80) 80/29
rs1158867 PROC 1.44 ppt 0.375(120) 0.200 (10) 10/4
rs13011342 PLCD4 1.54 bp 0.017(120) 0.000 (2) 2/1
rs2277382 ACVRL1 1.46 bp 0.075(120) 0.750 (8) 8/9
rs17602686 GLDN - bp 0.149(114) 0.000 (12) 12/15
rs366577 ENO3 1.08 59ss 0.392(120) 0.091 (99) 99/50
aParameters explained in text.
bIntronic motif region where the SNP lies: 59 splice site (59ss), 39 splice site (39ss), branch point (bp) or polypyrimidine tract (ppt).
doi:10.1371/journal.pone.0013340.t003
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which in turn might affect the efficiency of the spliceosome and
result in differential levels of alternatively spliced genes. Our
candidate STEP is located in the 59ss of a 59 UTR intron and by
transcript and EST evidence may result in the extension of exon 1,
varying UTR length and potentially Cyclophilin G expression.
Another high disease score was in DNA polymerase delta 2
(POLD2), part of the DNA polymerase delta complex of 4 proteins
which are involved in DNA replication and repair [26,27]. DNA
damage is widely thought to be related to cancer, aging and
neurological diseases [28–30]. This suggests that any candidate
STEPs for POLD2, which may cause a change in splicing efficiency
leading to differential protein expression, might affect the
efficiency of DNA repair and over a prolonged period affect the
risk of various degenerative diseases. POLD2 contains a candidate
STEP T.C polymorphism in the PPT of intron 2, where the
minor allele C would be expected to splice less efficiently by
consensus. However, EST evidence shows splicing to occur rarely
in comparison to the unspliced form, suggesting that other factors
may contribute to intron retention (such as a weak 59ss which may
lead to the activation of a 39ss in the upstream exon). Other
polymorphisms, e.g. rs3217947 - a T/G polymorphism in the 59ss
of intron 1, may also exhibit an effect in POLD2, but lack
population frequency data.
Bromodomain testis-specific (BRDT) is a protein similar to the
RING3 protein family and is thought to have a role in
transcriptional regulation in spermatogenesis [31]. Our results
showed a large increase in the MAF of rs11165878, perhaps due to
a lesser binding efficiency of the G allele to the spliceosome, which
may cause an increased rate of intron retention in an already weak
motif coupled with a relatively weak PPT (45% pyrimidine). There
is evidence that polymorphisms in this region can cause a greater
effect than polymorphisms at +3, +5 and +6 (beyond the obligatory
GT start) or can have a differential effect dependant on coupling
patterns of 59ss bases [32]. No strong association was found for this
SNP (or others in high LD with it) in 16 GWAS data sets (Table
S5). Since this gene is reported to have a potential role in
spermatogenesis its role in testicular cancer would be of interest,
but it was not reported as one of the top GWAS hits for testicular
cancer in Rapely et al. [33].
Finally, alpha-2-macroglobulin (A2M) contains a T.G poly-
morphism in the PPT which may lead to intron retention in the
final mRNA. Other studies into A2M have suggested a relation to
Alzheimer’s Disease [34–37]. Our candidate STEP, rs226380 was
not found to have any strong relationship to Alzheimer’s Disease
in any population studies where it was genotyped [36], although
other SNPs in linkage disequilibrium with this potential STEP
have (e.g. rs669, D’=1, r2=0.634) [37].
Unfortunately as the EST data are not traceable to specific
populations or to specific individuals, these data are purely
indicative of intron sequence retention and serve as a reference for
alleles known to be retained. The search for STEPs in this way is
also limited by candidate STEPs having to be retained in the
mRNA product. Many of the 469 candidate STEPs not reported
to have EST evidence of alternative splicing may exhibit an effect
leading to an upstream transcript start (where an upstream exon is
added by activation of an upstream splice site), intron extension
(by activation of a weaker splice site in the adjacent exon) or exon
skipping.
Splice site prediction
The use of splice site predictions serves as extra validation of
potential STEPs. Although 1980 candidate STEPs were reported
to have a score difference greater than zero, we retained for
further analysis only the set that had 2 or more score differences
greater than zero from the three prediction tools to eliminate the
effects of over-prediction from any one prediction tool. Figure S1
shows graphs of score difference values against other attributes
potentially descriptive of intron splicing. Zhang et al. [16]
suggested that GC-richness had an effect on consensus splice site
sequences, deriving two PWMs, one for GC-rich introns and the
other for GC-poor. Our graph shows no correlation between GC-
richness and score difference for any splice prediction tool,
suggesting that for a given candidate STEP, there is no differential
chance of an effect for GC-richness. Equally, one might expect
that the number of transcripts relating to a gene might relate to
score difference for a candidate STEP where STEPs are common,
perhaps through weaker splice sites facilitating alternative splicing.
Again no correlation was found. Finally, we checked for a relation
between score difference and intron length, where longer introns
may have weaker splice sites as longer sequences increase the
probability of having additional splice sites, but no correlation was
found.
A large proportion of candidate STEPs with EST evidence of
differential splicing also had score differences for 2 or more splice
prediction tools. A final set of 15 candidates was returned with
positive results for both search methods and population frequency
data to check for a real SNP. As we can see from Figure 1, there
was a lack of unity between the set of HapMap SNPs and the
SNPs available with EST evidence. Potentially many more of the
remaining 142 SNPs with EST evidence, but no HapMap
frequencies could be shown as putative STEPs if these data
became available. Better in silico prediction may be obtained with
greater understanding of the splicing process and in particular how
a STEP might inhibit the splicing machinery. Table 4 displays the
final 15 STEPs (a subset of Table 3) requiring further follow-up.
dbSTEP
The database of candidate STEPs (dbSTEP, http://dbstep.
genes.org.uk/) provides a resource for further follow-up of the
novel genetic mechanism of splice translational efficiency poly-
morphisms. Our database facilitates searches by gene, rs number,
gene and transcript IDs (Ensembl and Vega) or chromosomal
region, as well as filtering by motif region and variant type (SNP or
INDEL). Searches return a list of all possible transcript-intron-
STEP matches, which link to summary pages of annotations for
each candidate STEP and links to relevant external resources.
Successive variant frequency and transcript data updates will add
to this resource and aim to validate more candidate STEPs.
Future work
This study focused on human 59 non-coding intron 59 splice
sites, 39 splice sites (extending into the polypyrimidine tract) and
branch point sites. There is the potential to extend these
predictions to splice enhancers and silencers which would affect
the mRNA 59 leader; and to extend the database to other living
species using the same process which generated dbSTEP.
Improvements in SNP databases, 59 exon identifications and
motif predictions will all enable updates. Cross-reference annota-
tion using a 59 UTR functional elements database [13] may be
useful as knowledge of translational control expands.
Materials and Methods
Data collection
Data were collected using a suite of Perl scripts (available from
the authors on request), accessing Ensembl and Vega via the Perl
API (Bio::EnsEMBL) and other sources (dbSNP and HapMap) via
Genome-Wide Study of STEPs
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construct a database using MySQL (software version MySQL
5.0.67-0ubuntu6). This database was named dbSTEP (Figure 2).
Ensembl [38] provided all necessary variant (SNP and small
insertion/deletion) and transcript data for this project and was
synchronised regularly to remain up-to-date. Where available,
gene transcripts were also downloaded from the Vertebrate
Genome Annotation (Vega) database [39] at the Wellcome Trust
Sanger Institute, which provides a database of manually curated
transcript information aligned to a different chromosome build
from Ensembl (as of build 36). Data were entered into a core
relational database by chromosome, comprising tables of Ensembl
and Vega transcripts, tables of corresponding transcript-exons and
transcript-introns and tables of genetic variants. Tables were then
queried to create a public database with a subset of each table in
the core database, containing only candidate STEPs (i.e. variants
in conserved splicing sequences of a 59 UTR intron of a transcript),
their related transcript-introns and related flanking transcript-
exons. Finally, allele frequency data downloaded from HapMap
[40] were mapped to candidate variants in dbSTEP (HapMap
phase 3).
Annotation
Transcript sequences in dbSTEP were annotated according to
published consensus patterns and motifs. Table S1 lists annota-
tions made to transcript exons and introns for use in the online
database. The first of these is a count of exonic splice enhancers
(ESEs) [41], which gives the total occurrences of all candidate
ESEs in a given exon, taken from a previously published list of
hexamers. Other annotations include counts for each intron of: G-
triplets [42,43], a previously suggested intronic splicing enhancer
(ISE), and G-triplet pairs (pairs of GGG sequences fewer than 4
nucleotides apart).
The 59 donor splice site, 39 acceptor splice site and branch point
are key motifs in describing an intron and determining the binding
efficiency to the spliceosome. Previous research has identified
Table 4. Table of candidate STEPs with EST evidence (Table 3)
and splice site prediction.
SNP Gene Average Difference
rs2276611 PPIG 74.28
rs2236709 TTC12 45.34
rs1045761 TCEAL7 22.83
rs11165878 BRDT 22.49
rs9508887 PSPC1 19.73
rs2738364 PPP2R3B 17.51
rs226380 A2M 10.55
rs915942 RPL10 07.25
rs4881111 PITRM1 06.90
rs13011338 ZNF142 03.45
rs17207454 MSH5 02.14
rs924900 ZNF713 01.54
rs10912675 FMO1 01.30
rs4674259 CXCR2 00.37
rs2076689 PLCB1 00.35
A change in splice site recognition score was recorded in 2 or more prediction
tools for each candidate. For cases where no splice site was detected this is
asserted as 0 for the purposes of deriving a difference score.
doi:10.1371/journal.pone.0013340.t004
Figure 1. A Venn diagram of candidate STEP SNPs from our search. The circles contain all the candidate STEPs that have HapMap
frequencies, all of the candidate STEPs with evidence of either intron retention of exon extension or scored greater than zero in two or more splice
site prediction tools.
doi:10.1371/journal.pone.0013340.g001
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all introns start with the dinucleotide sequence GT and end AG by
the ‘‘obligate’’ GT-AG rule [45] (with the exception of very rare
GC-AG and AT-AC splicing [46,47]) and have specific base
preferences at a number of adjacent bases. Most polymorphisms in
a GT-AG sequence should result in no splicing at that site for one
allele. Here we have extracted 6 bases at the intron 59 end to
represent the donor splice site and 15 bases at the intron 39 end to
represent the acceptor splice site and part of the polypyrimidine
tract (PPT) for each intron. Recent research has derived a
consensus sequence of YTNAY (where N denotes any base A, C,
G or T) for the branch point in human, a short sequence towards
the end of an intron which recruits elements of the spliceosome to
begin the two step splicing process [48]. Introns were scanned for
branch point consensus matches within a region 21 to 34 bases
upstream of the 39 intron end according to Gao et al. [48]. Lastly,
introns were analysed for percentage GC and PPT richness. GC-
rich introns were scored separately from GC-poor introns in
scoring matrices in line with varying isochores [16,49]. PPT
richness influences recruitment of the polypyrimidine tract binding
protein (PTB), affecting alternative splicing [50,51].
Scoring
For evaluating possible absolute or relative efficiencies of intron
removal from the final mRNA, allelic score differences were
calculated for 59 splice, 39 splice and branch point consensuses
(respectively 6, 15 and 5 base lengths) by computing the difference
in base likelihood for the allelic bases observed at the relevant base
position in the consensus. Thus a change involving an obligate
base would score 1, a transition at a random position irrelevant to
the consensus would score 0.1, since average AT base pair
frequency is 0.4, average CG base pair frequency 0.6 in the
human genome. The position weight matrices (PWMs) of Zhang
et al. [16] (which also take account of intron percentage GC-
richness above or below 50%) were used for this calculation for
intron boundaries and the PWM of Gao et al. [48] was used for
branch points (see Tables S2, S3, S4). It was assumed that the
importance of location in the effect on the splice consensus is
already represented in the relative bias toward usage of a specific
base at that position, i.e. that periodicity and coupling effects for
nearby bases are minor [52].
For evaluating possible STEP effects across a range of common
diseases SNP data were cross referenced to publicly released
genome-wide association data (Table S5) using linkage disequilib-
rium information in HapMap [40] to identify nearby SNPs in
allelic association with the candidate STEP. Graphical plots show -
log10(p-value) versus linkage disequilibrium r
2 for each relevant
SNP within publicly available data (for thirteen separate diseases,
see Table S5). This was implemented in a local MySQL database
and will be expanded as and when such studies can make p-value
data available. To provide an immediate indicator of disease/
functional relevance, the highest product of r
2 and -log10(p-value)
(‘‘disease impact’’) is calculated as a descriptive disease score for
the 13 diseases and is displayed in dbSTEP search results. This
score provides an estimate of disease association by using the
linkage disequilibrium score (range 0 to 1, where 1 is perfect
linkage disequilibrium) as a weighting for the p-value for a given
SNP.
Splicing prediction
Candidate STEPs alleles were systematically submitted in the
sequence context of their transcript-intron to a series of online
splicing prediction algorithms to generate an in silico prediction of
splicing efficiency via recognition of the 39 and 59 splice sites
(Figure 3). Sequences for each SNP allele covering 60 nucleotides
around a transcript splice site (20 exonic, 40 intronic) were
scanned using three splice site prediction tools: Human Splicing
Finder (version 2.4) [18], NNSPLICE (version 0.9) [19] and
NetUTR (version 1.0b) [20]. Splice site sequences, instead of full
intron sequences, were scanned as the length of some introns
exceeded the limit allowed by all splice site prediction tools. A Perl
script was used to build each 60 nucleotide sequence from the
database and submit to the relevant online tools before analysing
the results. Results returned for each submitted sequence were
checked for the correct prediction of the splice site and prediction
scores submitted to dbSTEP. Where the transcript splice site was
not predicted no score was recorded. A difference score between
SNP alleles was derived, the difference being equal to the
predicted splice site score where a splice site was not found for
the opposing allele.
Figure 2. Diagram showing data sources and flow in generat-
ing dbSTEP. Variant and transcript information is collected through
the Ensembl API (Application Programming Interface) and annotated
along with other data collected from HapMap and local GWAS
(Genome-Wide Association Study) repositories. Data in dbSTEP are
then scored and mined for candidate STEPs (Splice Translational
Efficiency Polymorphisms).
doi:10.1371/journal.pone.0013340.g002
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Using the list of candidate STEPs obtained through SNP and
gene transcript data, exon structure around each candidate was
scanned to split the list into those that are possibly intron retaining
(exon spans the whole intron), splice to alternative splice sites
(introns exist that overlap intron with SNP, but do not share the
same start and end positions) or cause an upstream transcript start
(no overlapping introns or exons) (see Figure 4). In addition to
candidate STEPs in the intron retaining group, all STEPs that
were found to be both intronic and exonic by transcript evidence
were checked for EST evidence of splicing and partial intron
retention.
We used the list of intron retaining candidate STEPs and each
corresponding intron sequence that may be retained to search
EST databases for evidence of intron retention in vivo (Figure 3). A
search for RNA-Seq libraries for evidence of spliced and unspliced
forms yielded none in the public domain. Using Perl scripts we
queried the online NCBI BLAST website (http://blast.ncbi.nlm.
nih.gov/) [53] and submitted fragments of sequence for alignment
against dbEST [17]. For each STEP-intron case regarding
complete intron retention, we submitted 2 whole intron sequences
(one for each allele of the STEP) and another 40-base sequence
spanning the exon-exon junction of the spliced form (where the
junction exists between bases 20 and 21). For partially retained
sequences two 41-base sequences (20 flanking candidate STEP)
were submitted along with the 40-base exon-exon junction. Intron
and exon sequences were taken from one Ensembl or Vega
transcript in each case where the STEP was predicted to have an
Figure 3. Diagram showing data flow in deriving a final potential STEP list. Candidate STEPs were scanned for splice site prediction
differences via 3 online tools as well as filtered for candidates which are retained (causing full intron retention of exon extension) and checked via a
BLAST search of EST databases. These results are then combined to derive a final intron retaining STEP list.
doi:10.1371/journal.pone.0013340.g003
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where the resulting subject sequence was the full length of the
query sequence, with gaps allowed. Each intronic subject sequence
was parsed for which allele occurred for our STEP and the
quantity recorded along with the quantity of spliced forms. If a
given STEP-intron case had evidence of the spliced form as well as
a bias in the number of STEP alleles relative to population allele
frequency in the intron sequence it was shortlisted as a putative
STEP (Table 3).
dbSTEP online database
An online interface to the dbSTEP database was created using
Perl common gateway interface (CGI) scripts running under
Apache2 (http://www.apache.org/) on a Linux webserver. The
interface was designed to provide user-friendly graphical access to
the MySQL database generated by our genome-wide STEP
analysis, and is accessible at http://dbstep.genes.org.uk/.
Supporting Information
Table S1 Annotations made on transcript introns.
Found at: doi:10.1371/journal.pone.0013340.s001 (0.13 MB
PDF)
Table S2 Scoring matrix for 5’ donor splice sites based on
matrices from Zhang et al. (1998), where 1 is the first base of the
intron and the scores are the probability of a base not appearing at
a position.
Found at: doi:10.1371/journal.pone.0013340.s002 (0.17 MB
PDF)
Table S3 Scoring matrix for 39 acceptor splice sites based on
matrices from Zhang et al. (1998), where -1 is the last base of the intron
and the scores are the probability of a base not appearing at a position.
Found at: doi:10.1371/journal.pone.0013340.s003 (0.18 MB
PDF)
Table S4 Scoring matrix for branch points based on matrices
from Gao et al. (2008), where 0 is the location of the branch point
and the scores are the probability of a base not appearing at a
position.
Found at: doi:10.1371/journal.pone.0013340.s004 (0.16 MB
PDF)
Table S5 List of 16 GWAS data sets used to look for disease
association. These data sets were downloaded from the study
website upon their original release.
Found at: doi:10.1371/journal.pone.0013340.s005 (0.14 MB
PDF)
Figure S1 A, B and C show plots of allele difference scores from
in silico prediction tools against 3 different attributes which may
relate to STEPs: Number of transcripts (A), GC-richness (B) and
intron length (C). Blue points are NNSplice results, green points
are NetUTR results and red points are HSF results.
Found at: doi:10.1371/journal.pone.0013340.s006 (0.36 MB
PDF)
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Figure 4. Box diagram of aligned alternative splicing patterns in relation to a given splice form. A. Boxes are exonic and lines are intronic.
Vertical bands denote splice site motif regions where a STEP may occur. A shows a standard splice form with a single intron. B shows partial intron
retention or extension of either exon, as well as exon skipping. C shows full intron retention. D shows an upstream exon activated by a splice site.
doi:10.1371/journal.pone.0013340.g004
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